Shortage reports
Actual shortage:
8 (10%)
Anticipated shortage:
0 (0%)
Avoided shortage:
1 (1%)
Resolved:
74 (89%)
83
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
4 (57%)
Reversed:
3 (43%)
7
9 (10%)
4 (50%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VISUDYNE | 15MG | POWDER FOR SOLUTION | Resolved | 2022-07-20 | 2022-08-13 | 165082 |
| VISUDYNE | 15MG | POWDER FOR SOLUTION | Resolved | 2020-08-31 | 2022-02-11 | 123386 |
| XENICAL | 120MG | CAPSULE | Resolved | 2021-05-13 | 2021-08-10 | 139254 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ANANDRON | 50MG | TABLET | Reversed | 2024-05-16 | 2024-07-10 | 228155 |
| LOSEC | 20MG | TABLET (DELAYED-RELEASE) | Discontinued | 2021-11-19 | 2021-11-19 | 149669 |
| SUPREFACT | 100MCG | SOLUTION | Discontinued | 2021-12-13 | 2021-12-13 | 151039 |
| SUPREFACT DEPOT 2 MONTHS | 6.3MG | IMPLANT | Reversed | 2024-05-16 | 2024-06-19 | 228169 |
| SUPREFACT DEPOT 3 MONTHS | 9.45MG | IMPLANT | Reversed | 2024-05-16 | 2024-07-10 | 228166 |
| XELODA | 150MG | TABLET | Discontinued | 2022-11-30 | 2022-12-01 | 176355 |
| XELODA | 500MG | TABLET | Discontinued | 2022-11-30 | 2022-12-01 | 176359 |
Showing 1 to 7 of 7